Literature DB >> 19398645

Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration.

Meng Li1, Marilee A Andrew, Joanne Wang, David H Salinger, Paolo Vicini, Richard W Grady, Brian Phillips, Danny D Shen, Gail D Anderson.   

Abstract

Cranberry juice consumption is often recommended along with low-dose oral antibiotics for prophylaxis for recurrent urinary tract infection (UTI). Because multiple membrane transporters are involved in the intestinal absorption and renal excretion of beta-lactam antibiotics, we evaluated the potential risk of pharmacokinetic interactions between cranberry juice and the beta-lactams amoxicillin (amoxicilline) and cefaclor. The amoxicillin-cranberry juice interaction was investigated in 18 healthy women who received on four separate occasions a single oral test dose of amoxicillin at 500 mg and 2 g with or without cranberry juice cocktail (8 oz) according to a crossover design. A parallel cefaclor-cranberry juice interaction study was also conducted in which 500 mg cefaclor was administered with or without cranberry juice cocktail (12 oz). Data were analyzed by noncompartmental methods and nonlinear mixed-effects compartmental modeling. We conclude that the concurrent use of cranberry juice has no significant effect on the extent of oral absorption or the renal clearance of amoxicillin and cefaclor. However, delays in the absorption of amoxicillin and cefaclor were observed. These results suggest that the use of cranberry juice at usual quantities as prophylaxis for UTI is not likely to alter the pharmacokinetics of these two oral antibiotics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19398645      PMCID: PMC2704661          DOI: 10.1128/AAC.00774-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Possible interaction between warfarin and cranberry juice.

Authors:  Rafe Suvarna; Munir Pirmohamed; Leigh Henderson
Journal:  BMJ       Date:  2003-12-20

Review 2.  The role of cranberry juice in the treatment of urinary tract infections.

Authors:  Peter Griffiths
Journal:  Br J Community Nurs       Date:  2003-12

3.  Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women.

Authors:  T Kontiokari; K Sundqvist; M Nuutinen; T Pokka; M Koskela; M Uhari
Journal:  BMJ       Date:  2001-06-30

4.  Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.

Authors:  George K Dresser; David G Bailey; Brenda F Leake; Ute I Schwarz; Paul A Dawson; David J Freeman; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2002-01       Impact factor: 6.875

Review 5.  Cefaclor revisited.

Authors:  B R Meyers
Journal:  Clin Ther       Date:  2000-02       Impact factor: 3.393

Review 6.  Children's UTIs in the new millennium. Diagnosis, investigation, and treatment of childhood urinary tract infections in the year 2001.

Authors:  C T White; D G Matsell
Journal:  Can Fam Physician       Date:  2001-08       Impact factor: 3.275

7.  A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women.

Authors:  Lynn Stothers
Journal:  Can J Urol       Date:  2002-06       Impact factor: 1.344

8.  Characterization of uremic toxin transport by organic anion transporters in the kidney.

Authors:  Tsuneo Deguchi; Hiroyuki Kusuhara; Akira Takadate; Hitoshi Endou; Masaki Otagiri; Yuichi Sugiyama
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

9.  The presence of urinary nitrites is a significant predictor of pediatric urinary tract infection susceptibility to first- and third-generation cephalosporins.

Authors:  Dany Weisz; Jamie A Seabrook; Rodrick K Lim
Journal:  J Emerg Med       Date:  2008-08-30       Impact factor: 1.484

Review 10.  The effects of fruit juices on drug disposition: a new model for drug interactions.

Authors:  G K Dresser; D G Bailey
Journal:  Eur J Clin Invest       Date:  2003-11       Impact factor: 4.686

View more
  6 in total

1.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

2.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

Review 3.  Cranberries and lower urinary tract infection prevention.

Authors:  Marcelo Hisano; Homero Bruschini; Antonio Carlos Nicodemo; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

4.  Self-Medication with Antibiotics, Attitude and Knowledge of Antibiotic Resistance among Community Residents and Undergraduate Students in Northwest Nigeria.

Authors:  Olumide Ajibola; Olusola Akintoye Omisakin; Anthonius Anayochukwu Eze; Semeeh Akinwale Omoleke
Journal:  Diseases       Date:  2018-04-27

5.  Population Pharmacokinetic Analysis of Cefaclor in Healthy Korean Subjects.

Authors:  Seung-Hyun Jeong; Ji-Hun Jang; Hea-Young Cho; Yong-Bok Lee
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

6.  A Model-Based Pharmacokinetic/Pharmacodynamic Analysis of the Combination of Amoxicillin and Monophosphoryl Lipid A Against S. pneumoniae in Mice.

Authors:  Sebastian Franck; Robin Michelet; Fiordiligie Casilag; Jean-Claude Sirard; Sebastian G Wicha; Charlotte Kloft
Journal:  Pharmaceutics       Date:  2021-03-30       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.